Pharmaceutical News

RSS

A holistic approach key to minimize treatment complexity in patients with interstitial lung disease

Patients with interstitial lung disease—a group of disorders causing progressive scarring of lung tissue—are often prescribed various medications that specifically target their disease and others that treat their symptoms.

21 Feb 2019

Saffron may be a promising herbal alternative for treating ADHD

A new short-term pilot study in children and teens 6-17 years old with attention-deficit hyperactivity disorder has shown saffron to be as effective at controlling symptoms as methylphenidate, the commonly prescribed drug Ritalin.

21 Feb 2019

Cervical cancer could be eradicated by 2100

Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.

21 Feb 2019

Researchers discover a new promising target to improve HIV vaccines

In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus's outer envelope where a lineage of antibodies are able to dock and neutralize the virus.

21 Feb 2019

Some drug combinations may be more effective than others for schizophrenic patients

Patients with schizophrenia are often treated with more than one type of psychiatric medication, but a new study suggests that some combinations may be more effective than others.

21 Feb 2019

Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness

More than 70,000 Australians who suffer from chronic breathlessness will now have access to life-changing medication to manage their symptoms.

19 Feb 2019

Common acid reflux drugs tied to elevated risk for kidney disease

Proton pump inhibitors, which include well-known brand names Prilosec, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease.

19 Feb 2019

Drug combinations could become first-line treatment for metastatic kidney cancer

A combination of two drugs - one of them an immunotherapy agent - could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

18 Feb 2019

Cholesterol-lowering drugs could help prevent onset of motor neurone disease

High cholesterol has been found to be a possible risk factor for the development of motor neurone disease, according to a large study of genetic data led in the UK by Queen Mary University of London, in collaboration with the National Institutes of Health in the USA.

14 Feb 2019

Antidepressant drug could save people from deadly sepsis, research suggests

An antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research from the University of Virginia School of Medicine suggests.

14 Feb 2019

Study finds no association between antiepileptic drug use and dementia risk

Epilepsy is a common neurological condition with a prevalence of around 2%. Many antiepileptic drugs are available to prevent epileptic seizures, allowing up to 80 percent of patients to become seizure-free.

13 Feb 2019

CBD Lion announced as Headline Sponsor for CBD Expo MIDWEST

CBD Expo Tour 2019 produced by Mace Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, today announced CBD Lion as the Headline Sponsor for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

NHS doctors are over-prescribing pills, not therapy, for older people with depression

A systematic review of 27 studies has shown that GPs are too readily prescribing antidepressants to older individuals who are struggling with depression.

12 Feb 2019

Pill that reverses brain damage could be on the horizon

Researchers have made important progress in designing a drug that could recover brain function in cases of severe brain damage due to injury or disease.

12 Feb 2019

Contraceptive pill may impair women's ability to recognize emotions

A new study suggests that a woman’s ability to read emotions may be negatively impacted by the contraceptive pill.

12 Feb 2019

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.

12 Feb 2019

Machine learning algorithm could accelerate the search for new drugs

Researchers have designed a machine learning algorithm for drug discovery which has been shown to be twice as efficient as the industry standard, which could accelerate the process of developing new treatments for disease.

12 Feb 2019

FDA issues warning letters to companies for selling unapproved products that claim to treat Alzheimer’s

The U.S. Food and Drug Administration today posted 12 warning letters and 5 online advisory letters issued to foreign and domestic companies that are illegally selling more than 58 products, many that are sold as dietary supplements, which are unapproved new drugs and/or misbranded drugs that claim to prevent, treat or cure Alzheimer's disease and a number of other serious diseases and health conditions.

12 Feb 2019